Esperion Therapeutis.Inc. buy Wolf_of_WS
Summary
This prediction ended on 30.08.23 with a price of €1.46. The prediction had a final performance of 12.31%. Wolf_of_WS has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | -17.061% | -17.061% | 50.224% |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,28 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,40 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 27,89 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,25 % |
According to Wolf_of_WS what are the pros and cons of Esperion Therapeutis.Inc. for the foreseeable future?
Pros
Cons
Comments by Wolf_of_WS for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
In the thread Trading Esperion Therapeutis.Inc.
Stopped prediction by Wolf_of_WS for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
02.03.25
02.03.26
15.03.25
Esperion Therapeutis.Inc.
21.09.23
21.09.24
01.10.23
Esperion Therapeutis.Inc.
10.05.23
10.05.24
15.05.23
Esperion Therapeutis.Inc.
11.04.23
11.04.24
15.04.23


